Free Trial

Nutrien (NTR) Stock Forecast & Price Target

Nutrien logo
$49.65 -0.45 (-0.89%)
Closing price 03/31/2025 03:59 PM Eastern
Extended Trading
$49.24 -0.41 (-0.83%)
As of 03/31/2025 06:33 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nutrien - Analysts' Recommendations and Stock Price Forecast (2025)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Sell
2
Hold
5
Buy
8

Based on 15 Wall Street analysts who have issued ratings for Nutrien in the last 12 months, the stock has a consensus rating of "Hold." Out of the 15 analysts, 2 have given a sell rating, 5 have given a hold rating, and 8 have given a buy rating for NTR.

Consensus Price Target

$60.00
20.84% Upside
According to the 15 analysts' twelve-month price targets for Nutrien, the average price target is $60.00. The highest price target for NTR is $75.00, while the lowest price target for NTR is $50.00. The average price target represents a forecasted upside of 20.84% from the current price of $49.65.
Get the Latest News and Ratings for NTR and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Nutrien and its competitors.

Sign Up

NTR Analyst Ratings Over Time

TypeCurrent Forecast
4/1/24 to 4/1/25
1 Month Ago
3/2/24 to 3/2/25
3 Months Ago
1/2/24 to 1/1/25
1 Year Ago
4/2/23 to 4/1/24
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
8 Buy rating(s)
9 Buy rating(s)
11 Buy rating(s)
12 Buy rating(s)
Hold
5 Hold rating(s)
6 Hold rating(s)
4 Hold rating(s)
6 Hold rating(s)
Sell
2 Sell rating(s)
1 Sell rating(s)
3 Sell rating(s)
2 Sell rating(s)
Consensus Price Target$60.00$59.76$58.95$69.43
Forecasted Upside20.84% Upside14.02% Upside31.73% Upside26.56% Upside
Consensus Rating
Hold
Moderate Buy
Hold
Moderate Buy
Remove Ads

NTR Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

NTR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

Nutrien Stock vs. The Competition

TypeNutrienBasic Materials CompaniesS&P 500
Consensus Rating Score
2.40
2.78
2.54
Consensus RatingHoldModerate BuyModerate Buy
Predicted Upside20.84% Upside147.84% Upside19.04% Upside
News Sentiment Rating
Positive News

See Recent NTR News
Neutral News
Positive News
Remove Ads
DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
3/13/2025The Goldman Sachs Group
3 of 5 stars
A. Samuelson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageSell$53.00+4.44%
3/5/2025Barclays
3 of 5 stars
B. Theurer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$56.00 ➝ $59.00+20.08%
2/25/2025CIBC
3 of 5 stars
 Boost TargetOutperformer ➝ Outperformer$64.00 ➝ $66.00+24.22%
2/24/2025Royal Bank of Canada
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Andrew Wong
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform ➝ Outperform$60.00 ➝ $60.00+15.54%
2/24/2025Scotiabank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Ben Isaacson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetSector Outperform ➝ Sector Outperform$60.00 ➝ $62.00+19.22%
2/21/2025Wells Fargo & Company
Subscribe to MarketBeat All Access for the recommendation accuracy rating
R. Garchitorena
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetEqual Weight ➝ Equal Weight$53.00 ➝ $56.00+4.53%
2/20/2025Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Christopher Parkinson
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$52.00 ➝ $55.00+3.55%
2/20/2025UBS Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Spector
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetNeutral ➝ Neutral$53.00 ➝ $54.00+0.30%
1/27/2025Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
C. Neivert
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost TargetOverweight ➝ Overweight$58.00 ➝ $63.00+18.27%
1/13/2025JPMorgan Chase & Co.
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Jeffrey Zekauskas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeUnderweight ➝ Neutral$40.00 ➝ $50.00+3.18%
12/12/2024Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$60.00+25.31%
12/3/2024Raymond James
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Hansen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeMarket Perform ➝ Outperform$58.00 ➝ $60.00+25.63%
11/12/2024TD Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetBuy$63.00 ➝ $61.00+29.32%
8/9/2024BMO Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower TargetOutperform ➝ Outperform$80.00 ➝ $75.00+63.58%
8/2/2024Hsbc Global Res
Subscribe to MarketBeat All Access for the recommendation accuracy rating
S. Seshadri
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeHold ➝ Moderate Sell
8/2/2024HSBC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeHold ➝ Reduce
4/29/2024Berenberg Bank
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$60.00 ➝ $66.00+25.59%
3/26/2024Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$62.00+17.92%
3/1/2024Wolfe Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$66.00+26.36%
1/19/2024Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy ➝ Buy$72.00 ➝ $75.00+49.31%
11/30/2023BNP Paribas
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 DowngradeOutperform ➝ Neutral
7/25/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Reiterated RatingEqual Weight ➝ Equal Weight$70.00+5.69%
6/8/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$94.00 ➝ $85.00+44.73%
5/11/2023Credit Suisse Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Lower Target$70.00 ➝ $60.00-5.30%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Tuesday at 04:48 AM ET.


Should I Buy Nutrien Stock? NTR Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Friday, March 28, 2025. Please send any questions or comments about these Nutrien pros and cons to contact@marketbeat.com.

Nutrien
Bull Case

green Wall Street bull icon

Here are some ways that investors could benefit from investing in Nutrien Ltd.:

  • Nutrien Ltd. has recently seen a significant increase in institutional investment, with over 63% of its stock owned by institutional investors, indicating strong confidence in the company's future performance.
  • The company has a solid dividend yield of 4.28%, providing investors with a steady income stream. The recent dividend of $0.545 per share reflects Nutrien's commitment to returning value to shareholders.
  • Analysts have set a consensus price target of $60.00 for Nutrien Ltd., suggesting potential upside from the current stock price of $50.19, which could attract investors looking for growth opportunities.
  • Recent upgrades from multiple brokerages, including Raymond James and Royal Bank of Canada, have raised their ratings and price targets for Nutrien, indicating positive market sentiment and potential for stock appreciation.
  • Nutrien Ltd. operates in the essential agricultural sector, providing crop inputs and services, which positions it well to benefit from increasing global food demand and agricultural productivity.

Nutrien
Bear Case

red Wall Street bear icon

Investors should be bearish about investing in Nutrien Ltd. for these reasons:

  • The company's payout ratio is currently at 159.12%, which indicates that it is paying out more in dividends than it is earning. This could raise concerns about the sustainability of its dividend payments in the long term.
  • Despite positive analyst ratings, there are still two analysts who have issued sell ratings on Nutrien Ltd., suggesting that there are differing opinions on the stock's future performance.
  • The stock has recently experienced a decline of 4.5%, which may indicate volatility and could deter risk-averse investors from entering the market at this time.
  • Market conditions can be unpredictable, and fluctuations in commodity prices, which directly affect Nutrien's profitability, could pose risks to investors.
  • With increasing competition in the agricultural sector, Nutrien Ltd. may face challenges in maintaining its market share and profitability, which could impact investor confidence.

NTR Forecast - Frequently Asked Questions

According to the research reports of 15 Wall Street equities research analysts, the average twelve-month stock price forecast for Nutrien is $60.00, with a high forecast of $75.00 and a low forecast of $50.00.

15 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Nutrien in the last year. There are currently 2 sell ratings, 5 hold ratings and 8 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" NTR shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in NTR, but not buy additional shares or sell existing shares.

According to analysts, Nutrien's stock has a predicted upside of 20.84% based on their 12-month stock forecasts.

Over the previous 90 days, Nutrien's stock had 2 upgrades by analysts.

Nutrien has been rated by research analysts at Barclays, CIBC, JPMorgan Chase & Co., Mizuho, Piper Sandler, Royal Bank of Canada, Scotiabank, The Goldman Sachs Group, UBS Group, and Wells Fargo & Company in the past 90 days.

Analysts like Nutrien less than other "basic materials" companies. The consensus rating for Nutrien is Hold while the average consensus rating for "basic materials" companies is Moderate Buy. Learn more on how NTR compares to other companies.


This page (NYSE:NTR) was last updated on 4/1/2025 by MarketBeat.com Staff
From Our Partners